170 related articles for article (PubMed ID: 33957930)
1. Chronic cholestasis detection by a novel tool: automated analysis of cytokeratin 7-stained liver specimens.
Sjöblom N; Boyd S; Manninen A; Knuuttila A; Blom S; Färkkilä M; Arola J
Diagn Pathol; 2021 May; 16(1):41. PubMed ID: 33957930
[TBL] [Abstract][Full Text] [Related]
2. Automated image analysis of keratin 7 staining can predict disease outcome in primary sclerosing cholangitis.
Sjöblom N; Boyd S; Manninen A; Blom S; Knuuttila A; Färkkilä M; Arola J
Hepatol Res; 2023 Apr; 53(4):322-333. PubMed ID: 36495019
[TBL] [Abstract][Full Text] [Related]
3. Keratin 7 expression in hepatic cholestatic diseases.
Sakellariou S; Michaelides C; Voulgaris T; Vlachogiannakos J; Manesis E; Tiniakos DG; Delladetsima I
Virchows Arch; 2021 Oct; 479(4):815-824. PubMed ID: 34312700
[TBL] [Abstract][Full Text] [Related]
4. Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis.
Corpechot C; Gaouar F; El Naggar A; Kemgang A; Wendum D; Poupon R; Carrat F; Chazouillères O
Gastroenterology; 2014 Apr; 146(4):970-9; quiz e15-6. PubMed ID: 24389304
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of antioxidant responses in patients diagnosed with concomitant Primary Sclerosing Cholangitis/Inflammatory Bowel Disease.
Shearn CT; Orlicky DJ; Petersen DR
Exp Mol Pathol; 2018 Feb; 104(1):1-8. PubMed ID: 29180269
[TBL] [Abstract][Full Text] [Related]
6. norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis.
Fickert P; Hirschfield GM; Denk G; Marschall HU; Altorjay I; Färkkilä M; Schramm C; Spengler U; Chapman R; Bergquist A; Schrumpf E; Nevens F; Trivedi P; Reiter FP; Tornai I; Halilbasic E; Greinwald R; Pröls M; Manns MP; Trauner M;
J Hepatol; 2017 Sep; 67(3):549-558. PubMed ID: 28529147
[TBL] [Abstract][Full Text] [Related]
7. Collagen proportionate area correlates with histological stage and predicts clinical events in primary sclerosing cholangitis.
Saffioti F; Hall A; de Krijger M; Verheij J; Hübscher SG; Maurice J; Luong TV; Pinzani M; Ponsioen CY; Thorburn D
Liver Int; 2021 Nov; 41(11):2681-2692. PubMed ID: 34051052
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of immune-modulating therapy for primary sclerosing cholangitis: A systematic review and meta-analysis.
Liu X; Wang H; Liu X; Bridle K; Crawford D; Liang X
Pharmacol Ther; 2022 Sep; 237():108163. PubMed ID: 35271884
[TBL] [Abstract][Full Text] [Related]
9. Short-term prognostic factors for primary sclerosing cholangitis.
Watanabe T; Hirano K; Tada M; Isayama H; Mizuno S; Arizumi T; Toda N; Sugawara Y; Kokudo N; Koike K
J Hepatobiliary Pancreat Sci; 2015 Jun; 22(6):486-90. PubMed ID: 25826613
[TBL] [Abstract][Full Text] [Related]
10. An Imaging Biomarker for Assessing Hepatic Function in Patients With Primary Sclerosing Cholangitis.
Schulze J; Lenzen H; Hinrichs JB; Ringe B; Manns MP; Wacker F; Ringe KI
Clin Gastroenterol Hepatol; 2019 Jan; 17(1):192-199.e3. PubMed ID: 29775791
[TBL] [Abstract][Full Text] [Related]
11. CCL24 regulates biliary inflammation and fibrosis in primary sclerosing cholangitis.
Greenman R; Segal-Salto M; Barashi N; Hay O; Katav A; Levi O; Vaknin I; Aricha R; Aharoni S; Snir T; Mishalian I; Olam D; Amer J; Salhab A; Safadi R; Maor Y; Trivedi P; Weston CJ; Saffioti F; Hall A; Pinzani M; Thorburn D; Peled A; Mor A
JCI Insight; 2023 Jun; 8(12):. PubMed ID: 37345655
[TBL] [Abstract][Full Text] [Related]
12. Expression Analysis of ATP-Binding Cassette Transporters ABCB11 and ABCB4 in Primary Sclerosing Cholangitis and Variety of Pediatric and Adult Cholestatic and Noncholestatic Liver Diseases.
Thoeni C; Waldherr R; Scheuerer J; Schmitteckert S; Roeth R; Niesler B; Cutz E; Flechtenmacher C; Goeppert B; Schirmacher P; Lasitschka F
Can J Gastroenterol Hepatol; 2019; 2019():1085717. PubMed ID: 31886153
[TBL] [Abstract][Full Text] [Related]
13. Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: An international cohort study.
de Vries EM; de Krijger M; Färkkilä M; Arola J; Schirmacher P; Gotthardt D; Goeppert B; Trivedi PJ; Hirschfield GM; Ytting H; Vainer B; Buuren HR; Biermann K; Harms MH; Chazouilleres O; Wendum D; Kemgang AD; Chapman RW; Wang LM; Williamson KD; Gouw AS; Paradis V; Sempoux C; Beuers U; Hübscher SG; Verheij J; Ponsioen CY
Hepatology; 2017 Mar; 65(3):907-919. PubMed ID: 27880989
[TBL] [Abstract][Full Text] [Related]
14. Applicability and prognostic value of histologic scoring systems in primary sclerosing cholangitis.
de Vries EM; Verheij J; Hubscher SG; Leeflang MM; Boonstra K; Beuers U; Ponsioen CY
J Hepatol; 2015 Nov; 63(5):1212-9. PubMed ID: 26095184
[TBL] [Abstract][Full Text] [Related]
15. [Importance of liver puncture biopsy and endoscopic retrograde cholangiography in patients with chronic anicteric unexplained cholestasis. A retrospective study in 79 patients].
Sapey T; Turlin B; Canva-Delcambre V; Mendler MH; Deugnier Y; Brissot P; Guyader D
Gastroenterol Clin Biol; 1999 Feb; 23(2):178-85. PubMed ID: 10353011
[TBL] [Abstract][Full Text] [Related]
16. Interlobular bile duct loss in pediatric cholestatic disease is associated with aberrant cytokeratin 7 expression by hepatocytes.
Ernst LM; Spinner NB; Piccoli DA; Mauger J; Russo P
Pediatr Dev Pathol; 2007; 10(5):383-90. PubMed ID: 17929991
[TBL] [Abstract][Full Text] [Related]
17. Plasma antioxidant levels in chronic cholestatic liver diseases.
Floreani A; Baragiotta A; Martines D; Naccarato R; D'odorico A
Aliment Pharmacol Ther; 2000 Mar; 14(3):353-8. PubMed ID: 10735930
[TBL] [Abstract][Full Text] [Related]
18. IgG4-Related Sclerosing Cholangitis and Primary Sclerosing Cholangitis.
Tanaka A
Gut Liver; 2019 May; 13(3):300-307. PubMed ID: 30205418
[TBL] [Abstract][Full Text] [Related]
19. Expression of cytokeratin 7 as a histological marker of cholestasis and stages of primary biliary cirrhosis.
Barakauskienė A; Speičienė D; Liakina V; Semuchinienė T; Valantinas J
Medicina (Kaunas); 2011; 47(1):31-8. PubMed ID: 21681009
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of curcumin in primary sclerosing cholangitis: an open label pilot study.
Eaton JE; Nelson KM; Gossard AA; Carey EJ; Tabibian JH; Lindor KD; LaRusso NF
Scand J Gastroenterol; 2019 May; 54(5):633-639. PubMed ID: 31131678
[No Abstract] [Full Text] [Related]
[Next] [New Search]
